Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States

Cancer

Volumn 116, Issue 5, 2010, Pages 1367-1377

  Artinyan, Avo ^a   Mailey, Brian ^a   Sanchez Luege, Nicelio ^a   Khalili, Joshua ^a   Sun, Can Lan ^b,c   Bhatia, Smita ^b,c   Wagman, Lawrence D ^d   Nissen, Nicholas ^e   Colquhoun, Steven D ^e   Kim, Joseph ^a,b  

^a Division of Oncologic Surgery   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c Cedars Sinai Medical Center ^*  (United States)

^d ST JOSEPH HOSPITAL   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Ethnicity; Health disparity; Hepatocellular carcinoma; Race; Transplantation

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GRAFT SURVIVAL; HEALTH CARE ACCESS; HISPANIC; HUMAN; INCOME; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RACE; SOCIAL STATUS; UNITED STATES;

AFRICAN AMERICANS; ASIAN AMERICANS; CARCINOMA, HEPATOCELLULAR; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HEALTH STATUS DISPARITIES; HISPANIC AMERICANS; HUMANS; INCOME; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; SEER PROGRAM; SOCIAL CLASS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 77149160616     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24817     Document Type: Article

References (30)

1. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127(5 suppl 1): S27-S34.
2. Deuffic-Burban S, Poynard T, Sulkowski MS, Wong JB. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepat. 2007;14:107-115.
3. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000; 90:1562-1569.
4. El-Serag HB, Everhart JE. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000;95:3566-3573.
5. Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY. Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol. 2004;11:298-303.
6. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 2001;33:62-65.
7. Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006;4:104-110.
8. Sloane D, Chen H, Howell C. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc. 2006; 98:1934-1939.
9. Di Bisceglie AM, Lyra AC, Schwartz M, et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol. 2003;98: 2060-2063.
10. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94:334-357.
11. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817-823.
12. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Limited-Use Data (1973-2004). Bethesda, Md: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. April, 2008. Available at: http://www.seer.cancer.gov. Accessed November 2008.
13. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
14. United Network for Organ Sharing. UNOS data. Available at: http://www.unos.org/data/about/collection.asp, data received from UNOS February, 2008. Accessed November 2008.
15. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
16. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-871.
17. Poon RT. Current techniques of liver transection. HPB (Oxford). 2007;9:166-173.
18. Ishizaki Y, Kawasaki S. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol. 2008;43:18-26.
19. Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol. 2003;21:4329-4335.
20. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406.
21. Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698-708.
22. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int J Cancer. 2001;94:290-296.
23. Eckhoff DE, McGuire BM, Young CJ, et al. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation? Liver Transpl Surg. 1998;4:499-505.
24. Reid AE, Resnick M, Chang Y, Buerstatte N, Weissman JS. Disparity in use of orthotopic liver transplantation among blacks and whites. Liver Transpl. 2004;10:834-841.
25. Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371-2378.
26. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet. 2002;359:287-293.
27. Yoo HY, Thuluvath PJ. Outcome of liver transplantation in adult recipients: influence of neighborhood income, education, and insurance. Liver Transpl. 2004;10:235-243.
28. Aguilera V, Berenguer M, Rubin A, et al. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): post-transplantation outcome-comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis. Liver Transpl. 2009;15:79-87.
29. Smallwood GA, Coffey G, Davis L, Martinez E, Stieber AC, Heffron TG. Hepatitis C treatment outcomes of African Americans following liver transplantation. Transplant Proc. 2002;34:3317-3318.
30. Mehra MR, Uber PA, Scott RL, Park MH. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. Transplantation. 2002;74:1568-1573.